29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
On January 6, 2020, the Official Gazette of the Federation (Diario Oficial de la Federación) publish...
Read More >
In this week’s episode, Gary Qualls discusses the recent Louisiana federal district court decision ...
Read More >
FDI restrictions have been on the political agenda in Europe and further afield for at least the pas...
Read More >
One of my favorite sayings is that you should never make yourself a target, but when you are a mutua...
Read More >
On April 29, 2020, the US Treasury Department published an interim rule establishing fees for partie...
Read More >
On December 20, President Trump signed into law the “Setting Every Community Up for Retirement Enha...
Read More >